Publications
Journal Article
Paterson, David L., Sulaiman, Helmi, Liu, Po-Yu, Chatfield, Mark D., Yilmaz, Mesut, Salmuna, Zeti Norfidiyati, Mazlan, Mohd Zulfakar, Anunnatsiri, Siriluck, Sirijatuphat, Rujipas, Chotiprasitsakul, Darunee, Lye, David C., Somani, Jyoti, Kalimuddin, Shirin, Aslan, Abdullah T., Thamlikitkul, Visanu, Lee, Yi-Tzu, Yang, Ya-Sung, Lin, Yi-Tsung, Ramli, Wan Nurliyana Wan, Tseng, Chien-Hao, Archuleta, Sophia, Chan, Yvonne Fu Zi, Forde, Brian M., Wright, Hugh, Stewart, Adam G., Ramsay, Kay A., Ling, Weiping, Rossi, Vicki, Harris-Brown, Tiffany M. and Harris, Patrick N. A. (2025). Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trial. The Lancet Infectious Diseases, 26 (2), 148-159. doi: 10.1016/s1473-3099(25)00469-4